Lead Product(s) : Aviptadil Acetate
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Relief Therapeutics studies Aviptadil for Covid-19-related ARDS
Details : The multicenter trial will enroll patients who are already on mechanical ventilation to test whether Aviptadil can decrease mortality in this condition.
Product Name : Zyesami
Product Type : Peptide
Upfront Cash : Inapplicable
June 05, 2020
Lead Product(s) : Aviptadil Acetate
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable